Svenska Handelsbanken’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-17,000
Closed -$1.52M 47
2018
Q3
$1.52M Buy
17,000
+8,000
+89% +$707K 1.96% 24
2018
Q2
$715K Hold
9,000
1.02% 42
2018
Q1
$796K Hold
9,000
1.14% 39
2017
Q4
$939K Hold
9,000
1.27% 37
2017
Q3
$1.31M Hold
9,000
1.78% 27
2017
Q2
$1.17M Hold
9,000
1.77% 24
2017
Q1
$1.12M Buy
9,000
+4,400
+96% +$527K 1.5% 23
2016
Q4
$532K Hold
4,600
0.03% 52
2016
Q3
$481K Hold
4,600
0.04% 80
2016
Q2
$454K Hold
4,600
0.03% 97
2016
Q1
$460K Hold
4,600
0.05% 95
2015
Q4
$551K Buy
+4,600
New +$532K 0.06% 63

Other funds holding CELG

Svenska Handelsbanken's CELG Position: Q4 2018 in Review

Svenska Handelsbanken sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 17,000 shares — an estimated $1.52M sold.

Svenska Handelsbanken first reported a position in CELG in Q4 2015 and held it in 12 quarters. The position peaked at $1.52M in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Svenska Handelsbanken reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Svenska Handelsbanken sold 17,000 Celgene Corp shares in Q4 2018, an estimated $1.52M.
  • Svenska Handelsbanken first reported a position in Celgene Corp in Q4 2015 and held it in 12 quarters.
  • Svenska Handelsbanken's Celgene Corp position peaked at $1.52M in Q3 2018.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Svenska Handelsbanken's 13F filing for Q4 2018, filed 5 Feb 2019.